Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on: April 22,2024

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September

Updated on:April 22,2024

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on: February 01,2024

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on:February 01,2024

New method to determine before surgery which prostate tumors pose a lethal threat

by Cold Spring Harbor LaboratoryScreen shot from a new genome-viewing program (single cell genomic viewer, or SCGV) that displays results of CSHL's innovative method for analyzing diagnostic

Updated on: April 22,2024

New method to determine before surgery which prostate tumors pose a lethal threat

by Cold Spring Harbor LaboratoryScreen shot from a new genome-viewing program (single cell genomic viewer, or SCGV) that displays results of CSHL's innovative method for analyzing diagnostic

Updated on:April 22,2024

Researchers use AI to personalize cancer patient treatments

by University of SussexCredit: CC0 Public DomainResearchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyze different types of cancer cells to understand

Updated on: February 01,2024

Researchers use AI to personalize cancer patient treatments

by University of SussexCredit: CC0 Public DomainResearchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyze different types of cancer cells to understand

Updated on:February 01,2024

'Exhausted' immune cells in healthy women could be target for breast cancer prevention

byUniversity of CambridgeImmune cell exhaustion is observed in breast tissue from carriers of BRCA1 and BRCA2 mutations long before breast cancer develops. Credit: Sara Pensa/University of Cambr

Updated on: March 30,2024

'Exhausted' immune cells in healthy women could be target for breast cancer prevention

byUniversity of CambridgeImmune cell exhaustion is observed in breast tissue from carriers of BRCA1 and BRCA2 mutations long before breast cancer develops. Credit: Sara Pensa/University of Cambr

Updated on:March 30,2024

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent

Updated on: January 16,2024

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent

Updated on:January 16,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on: May 21,2024

New study estimates preventable cancer burden linked to poor diet in the US

by Tufts UniversityA new study estimates that 5.2 percent of new invasive cancer cases reported in 2015 are associated with poor diets. Credit: Nako Kobayashi/Tufts UniversityA new modeling study

Updated on:May 21,2024

Probing RNA epigenetics and chromatin structures to predict drug resistance in leukemia

by University of Chicago Medical Center5-AZA-sensitive and 5-AZA-resistant leukemia cells have distinctly different chromatin structures. Credit: Jason ChengDrug resistance is a major obstacle to

Updated on: March 09,2024

Probing RNA epigenetics and chromatin structures to predict drug resistance in leukemia

by University of Chicago Medical Center5-AZA-sensitive and 5-AZA-resistant leukemia cells have distinctly different chromatin structures. Credit: Jason ChengDrug resistance is a major obstacle to

Updated on:March 09,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024

Researchers uncover new targets for breast cancers resistant to standard therapies

by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b

Updated on: June 22,2024

Researchers uncover new targets for breast cancers resistant to standard therapies

by Leslie Cantu,Medical University of South CarolinaSOC therapy commonly induces DNA damage, BRCAness and toxic PARP1 trapping, leading to transcriptional blockage and growth inhibition in ER+ b

Updated on:June 22,2024